Search Results for 'Clopidogrel-Cyp2c19'

Clopidogrel-Cyp2c19 published presentations and documents on DocSlides.

Hepatic generation
Hepatic generation
by giovanna-bartolotta
of active metabolite. Pharmacogenetics. of Cardi...
x0000x0000                                   xAttxachex
x0000x0000 xAttxachex
by ani
�� ��NDA 20-839...
Canadian Cardiovascular Society
Canadian Cardiovascular Society
by test
Antiplatelet. Guidelines. INTERACTION BETWEEN CL...
Ticagrelor compared with clopidogrel in patients with acute
Ticagrelor compared with clopidogrel in patients with acute
by tatyana-admore
PLAT. elet Inhibition and patient . O. utcomes tr...
CPIC Term Standardization for
CPIC Term Standardization for
by Masterchief
Clinical Pharmacogenetic Test Results: Alleles and...
Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD,
Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD,
by shiloh201
Malhar Agarwal, MD, Megha Kureti, MD, Deepa Nagara...
Anti- Platelet   Therapy
Anti- Platelet Therapy
by tabitha
. Testing. . for. . Neurointerventional. . Proc...
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
by GratefulHeart
Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...
On behalf of the TRILOGY ACS Investigators
On behalf of the TRILOGY ACS Investigators
by lam
Prasugrel versus clopidogrel for patients with . U...
Antiplatelet Agents Mohammad Sistanizad
Antiplatelet Agents Mohammad Sistanizad
by blindnessinfluenced
Associate Professor of Clinical Pharmacy,. SBMU. C...
SERIES  OF 20 minutes
SERIES OF 20 minutes
by mitsue-stanley
SERIES OF 20 minutes CLINICAL HINTS AND Experi...
Antiplatelet  Therapy for Secondary Prevention in the First Year Following
Antiplatelet Therapy for Secondary Prevention in the First Year Following
by calandra-battersby
Antiplatelet Therapy for Secondary Prevention in...
Management of NSTE-ACS
Management of NSTE-ACS
by faustina-dinatale
Management of NSTE-ACS Dr shahinlal ACS v...
EVIDENCE-BASED MEDICINE FOR POST MI CARE
EVIDENCE-BASED MEDICINE FOR POST MI CARE
by phoebe-click
presented by . Paul St. Laurent, MSN, RN, ACNP, C...
Prasugrel  vs  ticagrelor in acute coronary syndromes
Prasugrel vs ticagrelor in acute coronary syndromes
by tawny-fly
Giuseppe . Biondi-Zoccai. , MD. Sapienza Universi...
Antiplatelet therapy in CAD
Antiplatelet therapy in CAD
by celsa-spraggs
Minilecture. Objectives. Indications for Antiplat...
Antiplatelet therapy in CAD
Antiplatelet therapy in CAD
by alexa-scheidler
Minilecture. Objectives. Indications for Antiplat...
Canadian Cardiovascular Society
Canadian Cardiovascular Society
by faustina-dinatale
Antiplatelet Guidelines. PERIOPERATIVE MANAGEMENT...
Antiplatelet
Antiplatelet
by mitsue-stanley
Therapy for Secondary Prevention . Beyond One Ye...
Stroke Prevention Update
Stroke Prevention Update
by luanne-stotts
Branko. N . Huisa. M.D.. Assistant Professor of...
EVIDENCE-BASED MEDICINE FOR POST MI CARE
EVIDENCE-BASED MEDICINE FOR POST MI CARE
by mitsue-stanley
presented by . Paul St. Laurent, MSN, RN, ACNP, C...
Canadian Cardiovascular Society
Canadian Cardiovascular Society
by briana-ranney
Antiplatelet Guidelines. MANAGEMENT OF ANTIPLATEL...
Unstable angina and NSTEMI - in association with NICE
Unstable angina and NSTEMI - in association with NICE
by liane-varnes
د. حسين محمد جمعة . اختصاØ...
Canadian Cardiovascular Society
Canadian Cardiovascular Society
by sherrill-nordquist
Antiplatelet Guidelines. MANAGEMENT OF ANTIPLATEL...
Antiplatelet
Antiplatelet
by alexa-scheidler
Therapy for Secondary Prevention . Beyond One Ye...
2C19 and 3A4 The most sensitive enzyme CYP2C19 was further cruris The
2C19 and 3A4 The most sensitive enzyme CYP2C19 was further cruris The
by summer
Study 1Study 2LUZUCream 1VehicleCream N103n LUZUC...
HIGHLIGHTS OF PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION
by caitlin
FULL PRESCRIBING INFORMATION INDICATIONS AND USAGE...
Biomarkers & Pharmacogenomics
Biomarkers & Pharmacogenomics
by debby-jeon
in CNS disorders. Subbu. . Apparsundaram. , PhD....
Biomarkers & Pharmacogenomics
Biomarkers & Pharmacogenomics
by conchita-marotz
in CNS disorders. Subbu. . Apparsundaram. , PhD....
Kristen K. Reynolds, PhD
Kristen K. Reynolds, PhD
by marina-yarberry
Associate Medical Director, VP Laboratory Operati...
Biomarkers & Pharmacogenomics
Biomarkers & Pharmacogenomics
by tatyana-admore
in CNS disorders. Subbu. . Apparsundaram. , PhD....
Randomized Comparison Duration Antiplatelet Therapy Implantation
Randomized Comparison Duration Antiplatelet Therapy Implantation
by theodore319
Hyeon-Cheol . Gwon. , . Joo. Yong Hahn, Young Bin...
Dual Anti-Platelet Therapy After TAVR?
Dual Anti-Platelet Therapy After TAVR?
by salem
By: Cole Smith PharmD Candidate 2021. University o...
Anti-platelet drugs Dr.
Anti-platelet drugs Dr.
by jaena
Ishfaq. . Bukhari. Dec. 2012. In healthy vascul...
Switching from dual antiplatelet therapy with aspirin plus a P2Y
Switching from dual antiplatelet therapy with aspirin plus a P2Y
by brown
12. inhibitor to dual pathway inhibition with asp...
COMPASS: Show Us the Way for Medical Management of PAD
COMPASS: Show Us the Way for Medical Management of PAD
by miller
Clinical Associate Professor of Medicine. SSM Heal...
Sumith   Aleti , MD, MPH, FACC
Sumith Aleti , MD, MPH, FACC
by dorothy
OHHI Cardiology Group. Antiplatelet and Anticoagul...